VentriPoint Diagnostisc Ltd. (VPTDF) 2D Diagnostics Tool Gives Unique Insight to Cardiovascular Awareness

Medical device company VentriPoint Diagnostics has created a diagnostic ultrasound tool to monitor patients with heart disease primarily in Canada and Europe, though the company has installed its Angelo (VMS™) heart visualization systems in the United States as well.

VMS is a 2D ultrasound imaging technology that eliminates disadvantages of an MRI scan without sacrificing accuracy. The VMS analytics software helps sonographers and cardiologist obtain correct and accurate coverage of the heart for analysis purposes, but side-steps less favorable features of an MRI, such as a long wait list, hour-long scan time, general anesthesia for children, and a second trip to the hospital for heart analysis.

The company recently installed one of its VMS systems at the Seattle Children’s Hospital, where it will be used for investigational purposes to study children with congenital and acquired heart disease. Dr. Brian Soriano, interim director of Echocardiography Laboratory for the Seattle Children’s Hospital, in a recent press release voiced his anticipation that the device will offer more accurate and precise ventricular volumes in a fraction of the cost and time as compared to traditional assessments.

“Cardiac MRI, considered the reference standard for ventricular volumes, is costly, requires a large amount of time to obtain images, and may be accessible only on a limited basis in some hospitals. When compared to traditional echocardiographic methods, VMS™ has the potential to offer more accurate and precise ventricular volumes in a time-efficient manner,” Dr. Soriano stated in the September press release.

Canada and Europe (CE Mark) have granted approval for the sale of VentriPoint’s VMS diagnostic tool; the company is pursuing U.S. FDA approval through the 510(k) process.

For more information, visit www.ventripoint.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html